|
|
|
|
|
|
|
|
|
|
Index of All Articles in the Chemotherapy Nausea Category
Defined Tag: Chemotherapy Nausea
Don’t Let Chemotherapy Nausea Get the Best of You
Unfortunately those patients that have the need for chemotherapy treatments have learned that many of the drugs that are used to keep cancers away can cause chemotherapy nausea When faced with this as a possible outcome of their treatment there are some th
Read More...
Other green Health Medical Topics To Check Out:
Adjuvant Chemotherapy
Carboplatin Chemotherapy
Chemotherapy Drug
Chemotherapy Nausea
Chemotherapy Protocols
Chemotherapy Treatments
Dose Dense Chemotherapy
Epoch Chemotherapy
Induction Chemotherapy
Leukemia Chemotherapy
|
||||||
Induction Chemotherapy News
| Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL (PR Newswire via Yahoo! Finance) Fri, 05 Sep 2008 14:55:00 GMT TopoTarget A/S announced that a positive reply from the FDA was received on a Special Protocol Assessment for a phase III trial for belinostat in PTCL . This pivotal trial is to enrol approximately 120 patients and is to begin in Q4 2008. |
| Peek at the Week (Niles Herald-Spectator) Thu, 04 Sep 2008 10:07:56 GMT Submissions for Community Calendar are required 10 days preceding the date of publication. Send to: Nicole Wagner, Managing Editor, Pioneer Press, 130 S. Prospect Avenue, Park Ridge IL 60068. Information may be faxed to (847) 696-3229 or e-mailed to nwagner@pioneerlocal.com. |
| ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer (Centre Daily Times) Wed, 03 Sep 2008 16:24:55 GMT ImClone Systems Incorporated (NASDAQ: IMCL) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) to broaden the use of ERBITUX(R) (cetuximab) to include first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). The application, submitted on August 29, 2008, was prepared in conjunction ... |